Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines

Parasitology

Volumn 138, Issue 11, 2011, Pages 1392-1399

  Ouakad, M ^a   Vanaerschot, M ^a,e   Rijal, S ^b   Sundar, S ^c   Speybroeck, N ^d   Kestens, L ^a   Boel, L ^a   De Doncker, S ^a   Maes, I ^a   Decuypere, S ^a   Dujardin, J C ^a,e  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b B P KOIRALA INSTITUTE OF HEALTH SCIENCES   (Nepal)

^c BANARAS HINDU UNIVERSITY   (India)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Antimony resistance; India; Leishmania donovani; META1; Metacyclogenesis; Nepal; SHERP; Visceral leishmaniasis

Indexed keywords

ANTIMONY; ARSENATE REDUCTASE; ARSENATE REDUCTASE 2; MEMBRANE PROTEIN; METACYCLIC PROTEIN 1; PROTOZOAL PROTEIN; SMALL HYDROPHILIC ENDOPLASMIC RETICULUM PROTEIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION PROFILING; IN VITRO STUDY; LEISHMANIA DONOVANI; MACROPHAGE; MATHEMATICAL MODEL; METACYCLOGENESIS; MICROSCOPY; MOLECULAR CLONING; NONHUMAN; PARASITE VIRULENCE; PATHOGENESIS; PRIORITY JOURNAL; PROMASTIGOTE;

ANIMALS; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; DRUG RESISTANCE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIFE CYCLE STAGES; MACROPHAGES; MOLECULAR TYPING; PROTOZOAN PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION;

LEISHMANIA DONOVANI;

EID: 79960942739     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182011001120     Document Type: Article

References (41)

1. Alam, M. Z., Kuhls, K., Schweynoch, C., Sundar, S., Rijal, S., Shamsuzzaman, A. K., Raju, B. V., Salotra, P., Dujardin, J. C. and Schönian, G. (2009). Multilocus microsatellite typing (MLMT) reveals genetic homogeneity of Leishmania donovani strains in the Indian subcontinent. Infection Genetics and Evolution 9, 24-31. doi: 10.1016/ j.meegid.2008.09.005
2. Alcolea, P. J., Alonso, A., Gómez, M. J., Moreno, I., Domínguez, M., Parro, V. and Larraga, V. (2010). Transcriptomics throughout the life cycle of Leishmania infantum: high down-regulation rate in the amastigote stage. International Journal for Parasitology 40, 1497-1516. doi: 10.1016/ j.ijpara.2010.05.013
3. Andersson, D. I. and Hughes, D. (2010). Antibiotic resistance and its cost: is it possible to reverse resistance? Nature Review Microbiology 8, 260-271. doi: 10.1038/nrmicro2319
4. Borrell, S. and Gagneux, S. (2009). Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis. The International Journal of Tuberculosis and Lung Disease 13, 1456-1466.
5. Cardoen, S., Van Huffel, X., Berkvens, D., Quoilin, S., Ducoffre, G., Saegerman, C., Speybroeck, N., Imberechts, H., Herman, L., Ducatelle, R. and Dierick, K. (2009). Evidence-Based semiquantitative methodology for prioritization of foodborne zoonoses. Foodborne Pathogens and Disease 6, 1083-1096. doi: 10.1089/fpd.2009.0291
6. Carter, K. C., Hutchison, S., Boitelle, A., Murray, H.W., Sundar, S. and Mullen, A. B. (2005). Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy. Parasitology 131, 747-757. doi: 10.1017/ S0031182005008486 (Pubitemid 41772371)
7. Chappuis, F., Sundar, S., Hailu, A., Ghalib, H., Rijal, S., Peeling, R.W., Alvar, J. and Boelaert, M. (2007). Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nature Reviews Microbiology 5, 873-882. doi: 10.1038/nrmicro1748
8. da Luz, R. I., Vermeersch, M., Dujardin, J. C., Cos, P. and Maes, L. (2009). In vitro sensitivity testing of Leishmania clinical field isolates: preconditioning of promastigotes enhances infectivity for macrophage host cells. Antimicrobial Agents Chemotherapy 53, 5197-5203. doi: 10.1128/ AAC.00866-09
9. Decuypere, S., Rijal, S., Yardley, V., De Doncker, S., Laurent, T., Khanal, B., Chappuis, F. and Dujardin, J. C. (2005). Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal. Antimicrobial Agents and Chemotherapy 49, 4616-4621. doi: 10.1128/AAC.49.11.4616-4621.2005 (Pubitemid 41552591)
10. Decuypere, S., Vanaerschot, M., Rijal, S., Yardley, V., Maes, L., de Doncker, S., Chappuis, F. and Dujardin, J. C. (2008). Gene expression profiling of Leishmania (Leishmania) donovani: overcoming technical variation and exploiting biological variation. Parasitology 135, 183-194. doi: 10.1017/S0031182007003782 (Pubitemid 351156582)
11. Desjeux, P. (2004). Leishmaniasis: current situation and new perspectives. Comparative Immunology, Microbiology and Infectious Diseases 27, 305-318. doi: 10.1016/j.cimid.2004.03.004 (Pubitemid 38842803)
12. Frézard, F., Demicheli, C. and Ribeiro, R. R. (2009). Pentavalent antimonials: new perspectives for old drugs. Molecules 14, 2317-2336. doi: 10.3390/molecules14072317
13. Gamboa, D., Torres, K., De Doncker, S., Zimic, M., Arevalo, J., Dujardin, J. C. (2008). Evaluation of an in vitro and in vivo model for experimental infection with Leishmania (Viannia) braziliensis and L. (V.) peruviana. Parasitology 135, 319-326. doi: 10.1017/S0031182007003848 (Pubitemid 351311226)
14. Haldar, A. K., Yadav, V., Singhal, E., Bisht, K. K., Singh, A., Bhaumik, S., Basu, R., Sen, P. and Roy, S. (2010). Leishmania donovani isolates with antimony-resistant but not -sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation. PLoS Pathogens 6, e1000907. doi: 10.1371/journal.ppat.1000907
15. Hastings, I. M. and Donnelly, M. J. (2005). The impact of antimalarial drug resistance mutations on parasite fitness, and its implications for the evolution of resistance. Drug Resistance Updates 8, 43-50. doi: 10.1016/ j.drup.2005.03.003 (Pubitemid 40797955)
16. Havelaar, A. H., van Rosse, F., Bucura, C., Toetenel, M. A., Haagsma, J. A., Kurowicka, D., Heesterbeek, J. H., Speybroeck, N., Langelaar, M. F., van der Giessen, J.W., Cooke, R. M. and Braks, M. A. (2010). Prioritizing emerging zoonoses in the Netherlands. PLoS ONE 5, e13965. doi: 10.1371/journal.pone. 0013965
17. Holzmuller, P., Sereno, D. and Lemesre, J. L. (2005). Lower nitric oxide susceptibility of trivalent antimony-resistant amastigotes of Leishmania infantum. Antimicrobial Agents and Chemotherapy 49, 4406-4409. doi: 10.1128/AAC.49.10.4406-4409.2005 (Pubitemid 41401001)
18. Knuepfer, E., Stierhof, Y. D., McKean, P. G. and Smith, D. F. (2001). Characterization of a differentially expressed protein that shows an unusual localization to intracellular membranes in Leishmania major. The Biochemical Journal 356, 335-344. (Pubitemid 32532343)
19. Martinez-Calvillo, S., Vizuet-de-Rueda, J. C., Florencio-Martinez, L. E., Manning-Cela, R. G. and Figueroa-Angulo, E. E. (2010). Gene expression in trypanosomatid parasites. Journal of Biomedicine and Biotechnology 525241. Epub. doi: 10.1155/2010/525241
20. Mikus, J. and Steverding, D. (2000). A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue. Parasitology International 48, 265-269.
21. Mookerjee Basu, J., Mookerjee, A., Sen, P., Bhaumik, S., Sen, P., Banerjee, S., Naskar, K., Choudhuri, S. K., Saha, B., Raha, S. and Roy, S. (2006). Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogenactivated protein kinase activation in Leishmania donovani-infected macrophages. Antimicrobial Agents and Chemotherapy 50, 1788-1797. doi: 10.1128/AAC.50.5.1788-1797.2006
22. Natera, S., Machuca, C., Padrón-Nieves, M., Romero, A., Díaz, E. and Ponte-Sucre, A. (2007). Leishmania spp.: proficiency of drug-resistant parasites. International Journal of Antimicrobial Agents 29, 637-642. doi: 10.1016/j.ijantimicag.2007.01.004 (Pubitemid 46710356)
23. Rijal, S., Chappuis, F., Singh, R., Bovier, P. A., Acharya, P., Karki, B. M., Das, M. L., Desjeux, P., Loutan, L. and Koirala, S. (2003). Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline. Transactions of the Royal Society of Tropical Medicine and Hygiene 97, 350-354. (Pubitemid 39185896)
24. Rijal, S., Yardley, V., Chappuis, F., Decuypere, S., Khanal, B., Singh, R., Boelaert, M., De Doncker, S., Croft, S. and Dujardin, J. C. (2007). Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome? Microbes and Infection 9, 529-535. doi: 10.1016/j.micinf.2007.01.009 (Pubitemid 46442794)
25. Sacks, D. L. (1989). Metacyclogenesis in Leishmania promastigotes. Experimental Parasitology 69, 100-103. (Pubitemid 19187905)
26. Samant, M., Sahasrabuddhe, A. A., Singh, N., Gupta, S. K., Sundar, S. and Dube, A. (2007). Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani. Parasitology 134, 1175-1184. doi: 10.1017/ S0031182007002569 (Pubitemid 47174067)
27. Saraiva, E. M., Pinto-da-Silva, L. H., Wanderley, J. L., Bonomo, A. C., Barcinski, M. A. and Moreira, M. E. (2005). Flow cytometric assessment of Leishmania spp metacyclic differentiation: validation by morphological features and specific markers. Experimental Parasitology 110, 39-47. doi: 10.1016/j.exppara.2005.01.004 (Pubitemid 40404075)
28. Sereno, D. and Lemesre, J. L. (1997). In vitro life cycle of pentamidineresistant amastigotes: stability of the chemoresistant phenotypes is dependent on the level of resistance induced. Antimicrobial Agents and Chemotherapy 41, 1898-1903. (Pubitemid 27383224)
29. Silva, N., Camacho, N., Figarella, K. and Ponte-Sucre, A. (2004). Cell differentiation and infectivity of Leishmania mexicana are inhibited in a strain resistant to an ABC-transporter blocker. Parasitology 128, 629-634. (Pubitemid 38789274)
30. Speybroeck, N., Berkvens, D., Mfoukou-Ntsakala, A., Aerts, M., Hens, N., Van Huylenbroeck, G. and Thys, E. (2004). Classification trees versus multinomial models in the analysis of urban farming systems in Central Africa. Agricultural Systems 80, 133-149. (Pubitemid 38307983)
31. Sundar, S. (2001). Drug resistance in Indian visceral leishmaniasis. Tropical Medicine & International Health 6, 849-854. (Pubitemid 33010870)
32. Thakur, C. P., Meenakshi Thakur, A. K. and Thakur, S. (2009). Newer strategies for the kala-azar elimination programme in India. The Indian Journal of Medical Research 129, 102-104.
33. Thakur, C. P., Mitra, D. K. and Narayan, S. (2003). Skewing of cytokine profiles towards T helper cell type 2 response in visceral leishmaniasis patients unresponsive to sodium antimony gluconate. Transactions of the Royal Society of Tropical Medicine and Hygiene 97, 409-412. (Pubitemid 39186020)
34. Kindt, R., Scheltema, R. A., Jankevics, A., Brunker, K., Rijal, S., Dujardin, J. C., Breitling, R., Watson, D. G., Coombs, G. H. and Decuypere, S. (2010). Metabolomics to unveil and understand phenotypic diversity between pathogen populations. PLoS Neglected Tropical Diseases 4, e904. doi: 10.1371/journal.pntd.0000904
35. Uliana, S. R., Goyal, N., Freymüller, E. and Smith, D. F. (1999). Leishmania: overexpression and comparative structural analysis of the stageregulated meta 1 gene. Experimental Parasitology 92, 183-191. doi: 10.1006/ expr.1999.4410 (Pubitemid 29370061)
36. Vanaerschot, M., Maes, I., Ouakad, M., Adaui, V., Maes, L., De Doncker, S., Rijal, S., Chappuis, F., Dujardin, J. C. and Decuypere, S. (2010). Linking in vitro and in vivo survival of clinical Leishmania donovani strains. PLoS One 5, e12211. doi: 10.1371/journal. pone.0012211
37. Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A. and Speleman, F. (2002). Accurate normalization of realtime quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 3, RESEARCH0034.
38. Walliker, D., Hunt, P. and Babiker, H. (2005). Fitness of drug-resistant malaria parasites. Acta Tropica 94, 251-259. doi: 10.1016/j.actatropica. 2005.04.005 (Pubitemid 40723640)
39. Wanderley, J. L., Pinto da Silva, L. H., Deolindo, P., Soong, L., Borges, V. M., Prates, D. B., de Souza, A. P., Barral, A., Balanco, J. M., do Nascimento, M. T., Saraiva, E. M. and Barcinski, M. A. (2009). Cooperation between apoptotic and viable metacyclics enhances the pathogenesis of Leishmaniasis. PLoS One 4, e5733. doi: 10.1371/journal. pone.0005733
40. Yardley, V., Ortuno, N., Llanos-Cuentas, A., Chappuis, F., Doncker, S. D., Ramirez, L., Croft, S., Arevalo, J., Adaui, V., Bermudez, H., Decuypere, S. and Dujardin, J. C. (2006). American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility? Journal of Infectious Diseases 194, 1168-1175. doi: 10.1086/507710 (Pubitemid 44547658)
41. Zakai, H. A., Chance, M. L. and Bates, P. A. (1998). In vitro stimulation of metacyclogenesis in Leishmania braziliensis, L. donovani, L. major and L. mexicana. Parasitology 116, 305-309. (Pubitemid 28186495)